Clinical Features of Pulmonary Hypertension

S. Gaine (Dublin, Ireland)

Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease

Number: 1

Disease area: Pulmonary vascular diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Gaine (Dublin, Ireland). Clinical Features of Pulmonary Hypertension. School Course 2012 - Pulmonary hypertension and pulmonary vascular disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Clinical and Epidemiological Features of Lung Cancer Complicated with Pulmonary Embolism Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018
Pulmonary Hypertension Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development Year: 2013
Pulmonary Hypertension Source: Eur Respir Rev 2009; 18: 193-194 Year: 2009
Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017
Pulmonary Hypertension in Childhood Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance Year: 2020
Pulmonary Hypertension in Pulmonary tuberculosis- A Prognostic Indicator Source: International Congress 2017 – Imaging and lung disease PH Year: 2017
Analysis of Causes of Diagnostic Difficulties and Features of Clinical Course of Pulmonary Embolism Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020
Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019
Clinical and Epidemiological Features of Tumor and Non-tumor Patients Complicated with Pulmonary Embolism Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017
A Minimal Clinically Important Difference for CAMPHOR in Idiopathic Pulmonary Arterial Hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020
Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021
Late Breaking Abstract - Clinical Efficacy and Safety of Macitentan Transitioned from Bosentan in Patients with Pulmonary Arterial Hypertension Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018
Cardiac MRI for Prognosis in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis Source: Virtual Congress 2020 – Imaging-based phenotyping in pulmonary disease Year: 2020